One month passed since last CPhI in Madrid. There, NTC team met more than 200 potential customers and suppliers coming from 50 countries all over the world.

NTC, the Italian pharmaceutical company, presented at the ESCRS (European Society of Cataract & Refractive Surgeons) Congress of Vienna the protocol of Leader7, one of the largest clinical trials in ophthalmology at European level of the last decade.

On September 22 nd, during the ESCRS Congress in Wien, NTC organizes a Satellite Symposium: "Rationalization of prescriptive behaviours in ophthalmology for the containment of antibiotic resistance".

Mexico City, 25 July 2018: Mundipharma has expanded its ophthalmology portfolio in Latin America by agreeing a new commercial partnership with NTC – an Italian pharmaceutical company with deep experience in research and development – for exclusive rights to license and distribute a range of ophthalmic medicines across the region...